BVMOs have been overexpressed in E. coli., and the list of reported Type I BVMOs has
grown significantly during recent years (Table 10.1).
They include several cyclohexanone monooxygenases [83, 84], a steroid mono-
oxygenase (SMO) [85], and cyclodecanone monoxygenase (CDMO). The latter was
the first characterized enzyme to catalyze BVoxidation of large cyclic compounds [86].
In 2001, overexpression systems in E. coli were engineered for 4-hydroxyacetophe-
none monooxygenase (HAPMO) [87] and for cyclopentanone monooxygenase
(CPMO) [88, 89]. Quite recently, BVMOs that readily accept phenylacetone deriva-
tives (PAMO) have been described [90]. Also, variants specific for acetone
(ACMO) [91], linear aliphatic ketones (AKMO) [92], and for the large cyclic ketone
cyclopentadecanone (CPDMO) [93] were reported.
Substrate-profiling studies suggest that BVMOs have a rather broad specificity and
often display overlapping substrate specificities. However, catalytic efficiencies and
regio- and/or enantioselectivities can differ significantly when comparing BVMOs.
Comparative biocatalytic studies using highly similar enzymes have revealed
that all studied CHMOs and CPMOs cover a similar substrate range [94–96],
although it was observed that CPMOs and CHMOs often display opposite
enantioselectivities [96].
Although BVMOs display broad substrate specificity, each type of BVMO has a
certain preference for a specific type of substrate. CHMO and CPMO are highly active
with a range of smaller cyclic aliphatic ketones, whereas HAPMO and PAMO prefer
aromatic substrates [87, 90, 97–99].
Directed Evolution of Enantioselective Enzymes for Catalysis in Baeyer-Villiger Reactions
Reetz and co-workers have demonstrated that the methods of directed evolution can
be applied successfully to the creation of enantioselective cyclohexanone monoox-
ygenases (CHMOs) as catalysts in Baeyer-Villiger reactions of several different
substrates, for which the enantioselectivity ranges between 90–99% [100]. Ketone
5 gives a very poor enantioselectivety (9% ee, R-selective) with the wild-type CHMO.
The enantioselectivety for 5 was significantly improved by directed evolution, and an
S-selective variant gave 79% ee (Scheme 10.1).
Recently, Reetz has devised a new strategy in directed evolution in order to
construct a robust experimental platform for asymmetric Baeyer-Villiger reactions
based on the thermostable phenylacetone monooxygenase (PAMO) [101]. Unfortu-
nately, the substrate scope of the wild-type (WT) PAMO is very limited, only accepting
phenylacetone and structurally similar linear phenyl-substituted ketones. By exploit-
ing bioinformatics data derived from sequence alignment of eight different BVMOs,
in conjunction with the known X-ray structure of PAMO, this problem could be
circumvented. Their goal was to expand the substrate scope, to increase the reaction
rate, and to reach high enantioselectivity without compromising thermostability.
Mutants were evolved which showed unusually high activity and enantioselectivity in
the oxidative kinetic resolution of a variety of structurally different 2-substituted aryl-
and alkylcyclohexanone derivatives and of a structurally unrelated bicyclic ketones.
It is interesting to note that WT PAMO favors the formation of 8 as the (1S,5R )-
enantiomer and also produces some 9 as the (1S,5R)-enantiomer, whereas the
360
j
10 Oxidation of Carbonyl Compounds